Johnson & Johnson director granted 180.956 DSUs

Johnson & Johnson director Marillyn A. Hewson received additional deferred share units as part of her director fee plan, increasing her DSU balance.

Rhea-AI Filing Summary

JOHNSON & JOHNSON (symbol: JNJ) is the issuer of record for a Form 4 filing submitted to the SEC. HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.

JOHNSON & JOHNSON (JNJ) reported that director Marillyn A. Hewson received a grant of 180.956 Deferred Share Units (DSUs) on September 8, 2026 as a deferred cash retainer under the company’s Deferred Fee Plan for Directors. After this award, she holds 16,049.417 DSUs directly.

The DSUs, including associated dividend equivalent rights, are to be settled in cash upon termination of her directorship, with each DSU tied to the fair market value of one share of Johnson & Johnson common stock on the business day prior to settlement.

Insider Trade Summary

Grant/Award: 180.956 shares

Grant/Award 1 txn

Insider HEWSON MARILLYN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units F1, F2	180.956	$276.31	$50K

Holdings After Transaction: Deferred Share Units — 16,049.417 contracts (Direct)

Footnotes (2)

1. F1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
2. F2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 180.956 units Reference value per Deferred Share Unit: $276.31 per unit Deferred Share Units held after transaction: 16,049.417 units

3 metrics

Deferred Share Units granted 180.956 units Grant to director Marillyn A. Hewson on September 8, 2026

Reference value per Deferred Share Unit $276.31 per unit Filed transaction price for the 180.956 DSU award

Deferred Share Units held after transaction 16,049.417 units Total DSUs directly held by Marillyn A. Hewson after the award

Key Terms

Deferred Share Units, dividend equivalent rights, Amended and Restated Deferred Fee Plan for Directors

3 terms

Deferred Share Units financial

"Acquisition of Deferred Share Units (DSU) for deferral of cash retainer"

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Amended and Restated Deferred Fee Plan for Directors financial

"under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

FAQ

What insider transaction did JNJ disclose for director Marillyn A. Hewson?

Johnson & Johnson disclosed that director Marillyn A. Hewson acquired 180.956 Deferred Share Units on September 8, 2026 as a grant under the company’s Deferred Fee Plan for Directors, increasing her directly held DSUs to 16,049.417.

What are the key terms of the Deferred Share Units granted to the JNJ director?

The Deferred Share Units (DSUs) granted to the JNJ director are settled in cash upon termination of her directorship. Each DSU represents the fair market value of one share of Johnson & Johnson common stock on the business day prior to the settlement date.

How many Deferred Share Units does the JNJ director hold after this Form 4 transaction?

After the September 8, 2026 award, Marillyn A. Hewson holds 16,049.417 Deferred Share Units directly, including DSUs and related dividend equivalent rights accrued under Johnson & Johnson’s director fee deferral plan.

Was the JNJ director’s Deferred Share Unit grant a market purchase or a compensation award?

The transaction was a grant/award acquisition of Deferred Share Units as a deferral of the director’s cash retainer under Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors, not a market purchase of common stock.

Does the JNJ Form 4 indicate a Rule 10b5-1 trading plan for this director award?

No. The Form 4 indicates no Rule 10b5-1 trading plan for this transaction. It is reported as a compensation-related award of Deferred Share Units under Johnson & Johnson’s director fee deferral plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 08:50 PM Accepted by SEC EDGAR 09/10/2026 - 08:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEWSON MARILLYN A

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	09/08/2026		A		180.956		(1)	(1)	Common Stock	180.956	$276.31	16,049.417(2)	D

Explanation of Responses:

1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Marillyn A. Hewson	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)